002044:SZSEMeinian Onehealth Healthcare Holdings Co., Ltd. Analysis

Meinian Onehealth is trading around CNY 6.08, barely above its immediate support at 6.07 and well below the calculated resistance of 7.32. The stock sits just under the 20‑day SMA (≈6.66) and 50‑day SMA (≈6.69), while the 200‑day SMA (≈5.62) remains comfortably lower, indicating a neutral technical stance. Momentum indicators are mixed: RSI is in the mid‑30s (≈36.7), suggesting limited upside pressure, and the MACD histogram is negative with a bearish signal line, reinforced by a decreasing volume trend.
Fundamentally, the company trades at an eye‑watering trailing PE of ~86.9 versus an industry average of ~26.4, yet a discounted cash‑flow model places fair value near CNY 7.71, implying roughly 16% upside. Revenue has contracted by about 4% YoY, but margins remain respectable (gross ~42%, operating ~16%) and cash generation is solid (free cash flow > CNY 2.4 bn). The dividend is modest (0.22% yield) with a low payout ratio (~19%), supporting sustainability. High debt‑to‑equity (~61%) and a beta near 0.2 suggest limited market volatility but the 30‑day price volatility is high at ~49%, reflecting a volatile trading environment.